{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:55:15Z","timestamp":1693115715894},"reference-count":88,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Venous thromboembolism is a well-known complication of oral contraception and hormonal replacement therapy. Inherited thrombophilia is viewed as an important determinant in modulating the effects of estrogens on thrombotic risk. An increasing number of kits for thrombophilic mutations [factor V Leiden, G20210A prothrombin and methylenetetrahydrofolate reductase (<\/jats:p>","DOI":"10.1515\/cclm.2006.103","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T06:52:08Z","timestamp":1147157528000},"source":"Crossref","is-referenced-by-count":8,"title":["Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening"],"prefix":"10.1515","volume":"44","author":[{"given":"Maria Grazia","family":"Andreassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Botto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Maffei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1086\/JCE200213407","article-title":"Ethical considerations of genetic testing","volume":"8","author":"Fleming","year":"2002","journal-title":"J Clin Ethics"},{"key":"ref781","first-page":"126","article-title":"Hormones and pregnancy : thromboembolic risks for women","volume":"79","author":"Kujovich","year":"2004","journal-title":"Br"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"10","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"ref461","first-page":"20210","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the prothrombin mutation","volume":"47","author":"De Stefano","year":"1999","journal-title":"Engl J Med"},{"key":"ref541","first-page":"285","article-title":"Hormone replacement therapy , prothrombotic mutations , and the risk of incident nonfatal myocardial infarction in postmenopausal women","volume":"55","author":"Psaty","year":"2001","journal-title":"J Am Med Assoc"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1656297","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"28","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"key":"ref751","first-page":"160","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"76","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low - estrogen combined estrogen - progestin oral contraceptives","volume":"73","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"ref551","first-page":"123","article-title":"Prevalence of moderate hyperhomocysteinemia in patients with early - onset venous and arterial occlusive disease","volume":"56","author":"Fermo","year":"1995","journal-title":"Ann Intern Med"},{"key":"ref81","first-page":"119","article-title":"What does a gene for heart disease mean ? A focus group study of public understandings of genetic risk factors","volume":"9","author":"Bates","year":"2003","journal-title":"Am J Med Genet"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden ( activated protein C resistance )","volume":"33","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.ATV.0000018301.91721.94","article-title":"Factor V Leiden , hormone replacement therapy , and risk of venous thromboembolic events in women with coronary disease","volume":"18","author":"Herrington","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/47.9.1597","article-title":"Laboratory investigation of thrombophilia","volume":"89","author":"Tripodi","year":"2001","journal-title":"Clin Chem"},{"key":"ref611","first-page":"536","article-title":"Intermediate homocysteinemia : a thermolabile variant of methylenetetrahydrofolate reductase","volume":"62","author":"Kang","year":"1988","journal-title":"Am J Hum Genet"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0037-1614213","article-title":"Third generation oral contraceptives and heritable thrombophilia as risk factors of non - fatal venous thromboembolism","volume":"36","author":"Andersen","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref391","first-page":"487","article-title":"Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden","volume":"40","author":"Rintelen","year":"1996","journal-title":"Br"},{"key":"ref511","first-page":"338","article-title":"High risk of cerebral - vein thrombosis in carriers of a prothrombin - gene mutation and in users of oral contraceptives","volume":"52","author":"Martinelli","year":"1998","journal-title":"Engl J Med"},{"key":"ref331","first-page":"344","article-title":"Increased risk of venous thrombosis in oral - contraceptive users who are carriers of factor V Leiden mutation","volume":"34","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"ref841","first-page":"340","article-title":"Bar - Am Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"85","author":"Kupferminc","year":"1999","journal-title":"Engl J Med"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V98.2.358","article-title":"den der Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency","volume":"26","author":"van Wijk","year":"2001","journal-title":"Blood"},{"key":"ref41","first-page":"330","article-title":"Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis","volume":"5","author":"Endler","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein Prediction of a cofactor for activated protein C","volume":"88","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref141","first-page":"112","article-title":"Oral contraceptives , hormone replacement therapy and thrombosis","volume":"15","author":"Rosendaal","year":"2001","journal-title":"Thromb Haemost"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives , hormone replacement therapy , thrombophilias and risk of venous thromboembolism : a systematic review The Thrombosis : Risk and Economic Assessment of Thrombophilia Screening ( TREATS ) Study","volume":"39","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"ref491","first-page":"20210","article-title":"Combined effect of factor V Leiden and prothrombin on the risk of venous thromboembolism pooled analysis of case - control studies including cases and controls Study Group for Pooled - Analysis in Venous Thromboembolism Erratum in","volume":"50","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost Thromb"},{"key":"ref821","first-page":"131","article-title":"The Thrombosis : Risk and Economic Assessment of Thrombophilia Screening ( TREATS ) Study Screening for thrombophilia in high - risk situations : a meta - analysis and cost - effectiveness analysis","volume":"83","author":"Wu","year":"2005","journal-title":"Br"},{"key":"ref241","first-page":"95","article-title":"Hylckama A novel polymorphism in the factor XIII subunit ( His Arg ) : relationship to subunit dissociation and venous thrombosis","volume":"25","author":"Komanasin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0015-0282(99)00360-X","article-title":"Thrombophilia - associated pregnancy wastage","volume":"86","author":"Blumenfeld","year":"1999","journal-title":"Fertil Steril"},{"key":"ref31","first-page":"126","article-title":"Genetic polymorphisms associated with venous and arterial thrombosis : an overview","author":"Kottke","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"ref261","first-page":"983","article-title":"A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers","volume":"27","author":"Mingozzi","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9149(99)00375-6","article-title":"Sieve Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation ( resistance to activated protein C )","volume":"45","author":"Glueck","year":"1999","journal-title":"Am J Cardiol"},{"key":"ref481","first-page":"1223","article-title":"The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both","volume":"49","author":"Martinelli","year":"2000","journal-title":"Br"},{"key":"ref701","first-page":"677","article-title":"Methylenetetrahydrofolate reductase polymorphism ( ) hyperhomocysteinemia and risk of ischemic cardiovascular disease and venous thromboembolism : prospective and case - control studies from the Copenhagen City Heart Study","volume":"71","author":"Frederiksen","year":"2004","journal-title":"Blood"},{"key":"ref631","first-page":"126","article-title":"Hyperhomocyst ( e ) inemia and thrombophilia","volume":"64","author":"Key","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"ref131","first-page":"321","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after : cohort and case - control analysis","volume":"14","author":"Jick","year":"1995","journal-title":"Br Med J"},{"key":"ref121","first-page":"344","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"13","author":"Vandenbroucke","year":"2001","journal-title":"Engl J Med"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood-2003-02-0443","article-title":"Hyperhomocysteinemia in cerebral vein thrombosis","volume":"59","author":"Martinelli","year":"2003","journal-title":"Blood"},{"key":"ref741","first-page":"677","article-title":"den der Folate , homocysteine levels , methylenetetrahydrofolate reductase T variant , and the risk of myocardial infarction in young women : effect of female hormones on homocysteine levels","volume":"75","author":"Tanis","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref181","first-page":"280","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women Heart and Estrogen \/ progestin Replacement Study ( HERS ) Research Group","volume":"19","author":"Hulley","year":"1998","journal-title":"J Am Med Assoc"},{"key":"ref661","first-page":"677","article-title":"Lack of association between the mutation in the - methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece","volume":"67","author":"Zalavras","year":"2002","journal-title":"Int Angiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1152\/jappl.2001.91.6.2776","article-title":"Invited review : pharmacogenetics of estrogen replacement therapy","volume":"2","author":"Herrington","year":"2001","journal-title":"J Appl Physiol"},{"key":"ref21","first-page":"121","article-title":"Interaction of hemostatic genetics with hormone therapy : new insights to explain arterial thrombosis in postmenopausal women","volume":"3","author":"Braunstein","year":"2002","journal-title":"Chest"},{"key":"ref421","first-page":"116","article-title":"Hormonal replacement therapy , prothrombotic mutations and the risk of venous thrombosis","volume":"43","author":"Rosendaal","year":"2002","journal-title":"Br"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2005-863799","article-title":"Laboratory detection of inherited thrombophilia : a historical perspective","volume":"80","author":"Mannucci","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"11","author":"Rosendaal","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-0037-1615380","article-title":"den Hyperhomocysteinemia and venous thrombosis : a meta - analysis","volume":"58","author":"Heijer","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13625180008500383","article-title":"Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism","volume":"38","author":"Spannagl","year":"2000","journal-title":"Eur Contracept Reprod Health Care"},{"key":"ref01","first-page":"164","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy : a clinical review","volume":"1","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/CVM-2-3-141","article-title":"Genetics University of Toronto Thrombophilia Study in Women : genetic and other risk factors for venous thromboembolism in women","volume":"69","author":"Ray","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1161\/CIRCULATIONAHA.105.565556","article-title":"Beau Yon de Jonage Estrogen and Thromboembolism Risk ( ESTHER ) Study Group Prothrombotic mutations , hormone therapy , and venous thromboembolism among postmenopausal women : impact of the route of estrogen administration","volume":"53","author":"Straczek","year":"2005","journal-title":"Circulation"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00001721-200201000-00011","article-title":"Prothrombotic effects and clinical implications of third - generation oral contraceptives use","volume":"41","author":"Lippi","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref201","first-page":"455","article-title":"G - polymorphism of the fibrinogen beta gene and deep vein thrombosis","volume":"21","author":"Renner","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"ref831","first-page":"791","article-title":"Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium","volume":"84","author":"Martinelli","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref731","first-page":"677","article-title":"The methylenetetrahydrofolate reductase polymorphism influences the homocysteine - lowering effect of hormone replacement therapy","volume":"74","author":"Brown","year":"1999","journal-title":"Mol Genet Metab"},{"key":"ref151","first-page":"288","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women s Health Initiative randomized controlled trial","volume":"16","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0049-3848(01)00384-X","article-title":"Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism","volume":"70","author":"Varela","year":"2001","journal-title":"Thromb Res"},{"key":"ref301","first-page":"346","article-title":"World distribution of factor V Leiden","volume":"31","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"ref111","first-page":"346","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"12","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000073588","article-title":"Thrombophilia in young women candidate to the pill : reasons for and against screening","volume":"82","author":"Cosmi","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"ref671","first-page":"677","article-title":"Hyperhomocysteinemia increases the risk of venous thrombosis independent of the mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients","volume":"68","author":"Morelli","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref561","first-page":"334","article-title":"den Hyperhomocysteinemia as a risk factor for deep - vein thrombosis","volume":"57","author":"Heijer","year":"1996","journal-title":"Engl J Med"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1022130217463","article-title":"Hyperhomocysteinemia , vascular function and atherosclerosis : effects of vitamins","volume":"60","author":"Haynes","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref341","first-page":"346","article-title":"Enhancement by factor V Leiden mutation of risk of deep - vein thrombosis associated with oral contraceptives containing a third - generation progestagen","volume":"35","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"ref231","first-page":"438","article-title":"de ten de Frequency of the TAFI A and factor XIIIA Val Leu polymorphisms in patients with objectively proven pulmonary embolism","volume":"24","author":"Zidane","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref531","first-page":"20210","article-title":"Sieve The effect of exogenous estrogen on atherothrombotic vascular disease risk relates to the presence or absence of the A prothrombin gene mutation : a cross - sectional study of hyperlipidemic women II","volume":"54","author":"Glueck","year":"2000","journal-title":"Circulation"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1053\/euhj.2001.3082","article-title":"Venous thromboembolism in young women ; role of thrombophilic mutations and oral contraceptive use","volume":"51","author":"Legnani","year":"2002","journal-title":"Eur Heart J"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00125817-200103000-00009","article-title":"ACMG Factor V Leiden Working Group American College of Medical Genetics consensus statement on factor V Leiden mutation testing","volume":"78","author":"Grody","year":"2001","journal-title":"Genet Med"},{"key":"ref411","first-page":"233","article-title":"der Oral contraceptives and venous thrombosis : different sensitivities to activated protein C in women using second - and third - generation oral contraceptives","volume":"42","author":"Rosing","year":"1997","journal-title":"Br"},{"key":"ref281","first-page":"369","article-title":"de Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"29","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0037-1614974","article-title":"Den Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep - vein thrombosis","volume":"65","author":"Kluijtmans","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref651","first-page":"677","article-title":"Mutations and of the - methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease","volume":"66","author":"Domagala","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref431","first-page":"530","article-title":"Thrombotic variables and risk of idiopathic venous thromboembolism in women aged years Relationships to hormone replacement therapy","volume":"44","author":"Lowe","year":"2000","journal-title":"Thromb Haemost"},{"key":"ref61","article-title":"The challenge of using SNPs in the understanding and treatment of disease","volume":"7","author":"Schifreen","year":"2002","journal-title":"Biotechniques"},{"key":"ref361","first-page":"20210","article-title":"Interaction between the mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"37","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref211","first-page":"4","article-title":"The PAI - gene polymorphism and deep vein thrombosis in patients with inherited thrombophilia","volume":"22","author":"Sartori","year":"2003","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref191","first-page":"131","article-title":"The HERS trial results : paradigms lost ? Heart and Estrogen \/ progestin Replacement Study","volume":"20","author":"Herrington","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1365-2362.2003.01185.x","article-title":"ACE DD genotype : an independent predisposition factor to venous thromboembolism","volume":"23","author":"Fatini","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Den Homocysteine , MTHFR and risk of venous thrombosis : a meta - analysis of published epidemiological studies","volume":"72","author":"Heijer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-2005-872396","article-title":"den Genetic determinants of plasma total homocysteine","volume":"61","author":"Gellekink","year":"2005","journal-title":"Semin Vasc Med"},{"key":"ref451","first-page":"20210","article-title":"ten van den The A mutation in the - untranslated region of the prothrombin gene and the risk for arterial thrombotic disease","volume":"46","author":"Franco","year":"1999","journal-title":"Br"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2005-863803","article-title":"MS Genetic testing for thrombophilia mutations","volume":"81","author":"Hertzberg","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"ref861","first-page":"109","article-title":"Laboratory markers in the diagnosis of venous thromboembolism","volume":"87","author":"Caprini","year":"2004","journal-title":"Circulation"},{"key":"ref161","first-page":"132","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease The Heart and Estrogen \/ progestin Replacement Study","volume":"17","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"ref291","first-page":"3","article-title":"A common genetic variation in the - untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"30","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2004.11.038","article-title":"Genomic medicine and thrombotic risk : who , when , how and why","volume":"6","author":"Federici","year":"2006","journal-title":"Int J Cardiol"},{"key":"ref471","first-page":"20210","article-title":"Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes ( factor V Leiden and prothrombin in Italian patients with venous thromboembolic disease","volume":"48","author":"De Stefano","year":"1999","journal-title":"Br"},{"key":"ref621","first-page":"677","article-title":"Analysis of the T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups","volume":"63","author":"Franco","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/clinchem\/47.9.1597","article-title":"Laboratory investigation of thrombophilia","volume":"32","author":"Tripodi","year":"2001","journal-title":"Clin Chem"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2006.44.issue-5\/cclm.2006.103\/cclm.2006.103.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2006.103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T10:56:47Z","timestamp":1683457007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/CCLM.2006.103\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":88,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1515\/cclm.2006.103","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}